Cinzia Bagalá
About
Cinzia Bagalá is a scholar working on Oncology, Cancer Research and Molecular Biology.
According to data from OpenAlex, Cinzia Bagalá has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Cinzia Bagalá's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (8 papers) and S100 Proteins and Annexins (8 papers). Cinzia Bagalá is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (8 papers) and S100 Proteins and Annexins (8 papers). Cinzia Bagalá collaborates with scholars based in Italy, United States and Canada. Cinzia Bagalá's co-authors include Raffaella Soldi, Igor Prudovsky, Thomas Maciag, Stephen Bellum, Anna Mandinova, Matteo Landriscina, Francesca Tarantini, Carlo Barone, Alessandra Cassano and Irene Graziani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Cinzia Bagalá
32 papers receiving 1.3k citations
Peers
Cinzia Bagalá
Thomas C. Caffrey United States
Yingyu Ma United States
Makiko Kawaguchi Japan
Zailong Qin China
Subhrajit Saha United States
Paul M. Grandgenett United States
Keiichi I. Nakayama Japan
Grzegorz Kurzawski Poland
Bo Guo China
Daniel Lottaz Switzerland
Citations per year, relative to Cinzia Bagalá Cinzia Bagalá (= 1×)
peers
Thomas C. Caffrey
Countries citing papers authored by Cinzia Bagalá
Since
Specialization
Citations
This map shows the geographic impact of Cinzia Bagalá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Bagalá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Bagalá more than expected).
Fields of papers citing papers by Cinzia Bagalá
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Cinzia Bagalá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Bagalá. The network helps show where Cinzia Bagalá may publish in the future.
Co-authorship network of co-authors of Cinzia Bagalá
This figure shows the co-authorship network connecting the top 25 collaborators of Cinzia Bagalá. A scholar is included among the top collaborators of Cinzia Bagalá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinzia Bagalá. Cinzia Bagalá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lenkowicz, Jacopo, et al.. (2025). Prognostic impact of Geriatric 8 and comprehensive geriatric assessment in older patients with advanced pancreatic ductal adenocarcinoma. Journal of Geriatric Oncology. 17(1). 102782–102782.
2.
Salvatore, Lisa, Yangqing Deng, Faiyaz Notta, et al.. (2024). GATA6 expression in advanced pancreatic ductal adenocarcinoma (PDAC) as a prognostic and predictive biomarker in the Canadian COMPASS trial and the Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.. Journal of Clinical Oncology. 42(16_suppl). 4150–4150.
3.
Giorgio, Andrea Di, Cinzia Bagalá, Carmine Carbone, et al.. (2024). Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial). SHILAP Revista de lepidopterología. 9(3). 121–129.
4.
Chiaravalli, Marta, Cinzia Bagalá, Maria Bensi, et al.. (2024). Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis. The Lancet Oncology. 25(12). 1655–1665.
5.
Niger, Monica, Federico Nichetti, Sabina Murgioni, et al.. (2023). SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study. Annals of Oncology. 34. S162–S163.
6.
Mattiucci, Gian Carlo, Lisa Salvatore, Andrea D’Aviero, et al.. (2022). Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis. Oncology Research and Treatment. 45(10). 588–597.
7.
Chiaravalli, Marta, et al.. (2021). P-74 The impact of first-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective study. Annals of Oncology. 32. S122–S122.
8.
Giorgio, Andrea Di, Olivia Sgarbură, Stefano Rotolo, et al.. (2020). Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma. Therapeutic Advances in Medical Oncology. 12. 3863555927–3863555927.
9.
Rossi, Ernesto, Cinzia Bagalá, Frediano Inzani, et al.. (2018). RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer. In Vivo. 31(5). 833–840.
10.
Orlandi, Armando, Maria Alessandra Calegari, Maurizio Martini, et al.. (2016). Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse. Clinical & Translational Oncology. 18(10). 988–995.
11.
Orlandi, Armando, Mariantonietta Di Salvatore, Cinzia Bagalá, et al.. (2014). ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas. Journal of Cancer. 6(1). 70–81.
12.
Salvatore, Mariantonietta Di, Armando Orlandi, Cinzia Bagalá, et al.. (2011). Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line. Cell Proliferation. 44(2). 139–146.
13.
Inno, Alessandro, Michele A. Basso, Fabio Maria Vecchio, et al.. (2011). Anastrozole-related acute hepatitis with autoimmune features: a case report. BMC Gastroenterology. 11(1). 32–32.
14.
Inno, Alessandro, Mariantonietta Di Salvatore, Tonia Cenci, et al.. (2011). Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?. Clinical Colorectal Cancer. 10(4). 325–332.
15.
Aglietta, Massimo, C. Barone, Malcolm J. Moore, et al.. (2011). Final toxicity results of a phase I dose-escalation trial of tremelimumab (CP-675206) in combination with gemcitabine in chemotherapy-naive patients (pts) with metastatic pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). 4081–4081.
16.
Landriscina, Matteo, Cinzia Bagalá, Annamaria Piscazzi, et al.. (2009). Nevirapine restores androgen signaling in hormone‐refractory human prostate carcinoma cells both in vitro and in vivo. The Prostate. 69(7). 744–754.
17.
Graziani, Irene, Cinzia Bagalá, Maria F. Duarte, et al.. (2006). Release of FGF1 and p40 synaptotagmin 1 correlates with their membrane destabilizing ability. Biochemical and Biophysical Research Communications. 349(1). 192–199.
18.
Landriscina, Matteo, Cinzia Bagalá, Annamaria Piscazzi, et al.. (2005). Reverse Transcriptase Inhibitors Down-Regulate Cell Proliferationin Vitroandin Vivoand Restore Thyrotropin Signaling and Iodine Uptake in Human Thyroid Anaplastic Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 90(10). 5663–5671.
19.
Small, Deena, Д. В. Коваленко, Raffaella Soldi, et al.. (2003). Notch Activation Suppresses Fibroblast Growth Factor-dependent Cellular Transformation. Journal of Biological Chemistry. 278(18). 16405–16413.
20.
Landriscina, Matteo, Raffaella Soldi, Cinzia Bagalá, et al.. (2001). S100A13 Participates in the Release of Fibroblast Growth Factor 1 in Response to Heat Shock in Vitro. Journal of Biological Chemistry. 276(25). 22544–22552.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Thomas C. Caffrey Breakdown of academic impact, for papers by Yingyu Ma Breakdown of academic impact, for papers by Makiko Kawaguchi Breakdown of academic impact, for papers by Zailong Qin Breakdown of academic impact, for papers by Subhrajit Saha Breakdown of academic impact, for papers by Paul M. Grandgenett Breakdown of academic impact, for papers by Keiichi I. Nakayama Breakdown of academic impact, for papers by Grzegorz Kurzawski Breakdown of academic impact, for papers by Bo Guo Breakdown of academic impact, for papers by Daniel Lottaz